MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHSMEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHSMEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS

MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS

No trades
See on Supercharts

0A9G fundamentals

An in-depth look to MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS operating, investing, and financing activities

0A9G free cash flow for Q3 24 is -7.62 M USD. For 2023, 0A9G free cash flow was -21.21 M USD and operating cash flow was -21.21 M USD.

Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth